Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) | MicrobiomeTrials← Back to trialsNCT05114278
Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
TERMINATEDPHASE4INTERVENTIONAL
Trial Details
Start: 2022-07-08Est. Completion: 2022-07-08
Enrollment target: 1 participants Locations- Hôpital Cochin, Paris, France
Other microbiome trials you might be interested in
Celiac Disease
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropath…
Murrieta, United StatesEst. completion Sep 15, 2026
Lipid Metabolism DisordersLipid Metabolism, Inborn ErrorsCongenital Heart DiseaseInflammatory Bowel Disease (IBD)Rheumatic DiseasesCeliac Disease in ChildrenCeliac Disease in Adolescents
Preventive measures are increasingly coming to the forefront of medicine. Many of these measures can be implemented as e…
Jena, GermanyEst. completion Jan 31, 2027
Celiac Disease
The purpose of this clinical study is to learn more about celiac disease pathogenesis and clinical symptoms. In particul…
Pasadena, United StatesEst. completion May 1, 2027